Cisneros A, García J, Castellanos G, Ramírez AR

Language: Spanish
References: 16
Page: 629-633
PDF size: 467.36 Kb.

ABSTRACT

We report an autopsy case of a 57-year-old, without previous medical history, clinical manifestations and death associated with cardiac tamponade. The condition was interpreted clinically as autoimmune origin because the patient had no joint pain, fever, pericardial effusion or ANA. In healthy individuals may have elevated ANA titles due to solid neoplasms and infectious processes. The patient had recurrent pericardial effusion pericardial carcinomatosis conditioned by the sudden deterioration of hemodynamic function and death: a unique clinical situation. The authors propose the term CPC instead of “pericarditis carcinomatous” under which sharpens the pathogenesis of these alterations. Inflammation implicit in the term “pericarditis” is an epiphenomenon of the immune response result aroused in the host antigens associated with neoplastic cells and not the fundamental disease process.

REFERENCES

1. Escobar A, Beltrán R. Taponamiento cardiaco en pacientes con neoplasia primaria conocida. Revista CES Medicina 2002;16(1):3.

2. Domínguez AB, Linares P, Vivas S, Castañón C, et al. Cardiac tamponade as the first manifestation of gastric cancer recurrence. Gastroenterol Hepatol 2002;25:577.

3. Kobayashi M, Okabayashi T, Okamoto K, Namikawa T, Araki K. Clinicopathological study of cardiac tamponade due to pericardial metastasis originating from gastric cancer. World J Gastroenterol 2005;11(44):6899-6904.

4. Varvarigos N, Kamaradou H, Kourt A, Papavasiliou ED, et al. Cardiac Tamponade as the first manifestation of gastric cancerand remission after chemotherapy. Digestive Diseases and Sciences 2001;46(11):2333-2335.

5. Sakai Y, Minouchi K, Ohta H, Annen Y, Sugimoto T. Cardiac tamponade originating from primary gastric signet ring cell carcinoma. J Gastroenterol 1999;34(2):250-252.

6. Miyanari N, Iyama K, Baba H. A patient with 43 synchronous early gastric carcinomas with a Krukenberg tumor and pericardial metastasis. Gastric Cancer 2007;10(2):135-139.

7. Kusaba H, Fujihara M. Systemic chemotherapy of TS-1 and cisplatin for gastric signet-ring cell carcinoma presenting as cardiac tamponade. Med Oncol 2008;25(2):241-244.

8. Kohnoe S, Maehara Y, Takahashi I, Saito A, et al. Intrapericardial mitomycin C for the management of malignant pericardial effusion secondary to gastric cancer: case report and review. Chemotherapy 1994;40(1):57-60.

9. Funk L, Hartmann D. Symptomatic pericardial effusion as initial manifestation of gastric signet ring cell carcinoma. Dutch Wes Med 2003;128(16):870-873.

10. Adams BB, Mutasim DF. The diagnostic value of anti-nuclear antibody testing. Int J Dermatol 2000;39:887-891.

11. Gray W. Diagnostic cytopathology. 2th ed. London: Elsevier, 2003; p:103-244.

12. Adenle AD, Edwards JE. Clinical and pathologic features of metastatic neoplasms of the pericardium. Chest 1982;81;166-169.

13. Wilkes JD, Fidias P, Vaickus L, Perez RR. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer 1995;15(76):1377-1387.

14. Jacobs I, Bast RC. The CA 125 tumors-associated antigen: a review of the literature. Human Reprod 1989;4(1):1-12.

15. Tochi A, Costa G, Lepre L. The role of serum and gastric juice leves of carcinoembrionic antigen, CA19-9 and CA72.4 in patients with gastric cancer. J Cancer Res Clin Oncol 1998;124:450-455.

16. Taylor-Papadimitrou J, Finn OJ. Biology, biochemistry and immunology of carcinoma-associated mucins. Immunol Today 1997;108:105.